| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |